A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
AbbVie
Henan Cancer Hospital
International Extranodal Lymphoma Study Group (IELSG)
International Extranodal Lymphoma Study Group (IELSG)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Ruijin Hospital
Cellectar Biosciences, Inc.
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
University of Washington
The First Affiliated Hospital with Nanjing Medical University
Institute of Hematology & Blood Diseases Hospital, China
Massachusetts General Hospital
Fred Hutchinson Cancer Center
University of Ulm
First Affiliated Hospital of Zhejiang University
Fudan University
Dana-Farber Cancer Institute
Emory University
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
BeOne Medicines
The First Affiliated Hospital of Soochow University
International Extranodal Lymphoma Study Group (IELSG)
Sun Yat-sen University
Masonic Cancer Center, University of Minnesota
Brown University
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
University of Utah
University of Utah
Second Affiliated Hospital, School of Medicine, Zhejiang University
Memorial Sloan Kettering Cancer Center
University of Washington
Celgene
University of Washington
University of Miami
Regeneron Pharmaceuticals
The First Affiliated Hospital with Nanjing Medical University
University of Miami
University of California, Davis
National Taiwan University Hospital
Masonic Cancer Center, University of Minnesota
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota